DTIL - Precision BioSciences Inc. Sales Growth YoY (Last Twelve Months)

Graphic logo of precisionbiosciences.com (DTIL)

Year-over-year product sales dynamics for the TTM support the scalability of the Precision BioSciences (DTIL) patent portfolio, where DNA code licensing generates revenue without capital expenditures. The 6359.10 level reflects the current magnitude of the metric, which remains stable even during a recession due to the sovereign biotech cycle. Consequently, Precision BioSciences (DTIL) is building a unique cancer treatment ecosystem, cementing its status as a leader in genetic engineering.

Sales Growth YoY (Last Twelve Months): Precision BioSciences, Inc. (DTIL) for 02/11/2024 - 11/15/2026

precisionbiosciences.com (DTIL) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart Precision BioSciences, Inc.|DTIL - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Precision BioSciences, Inc.|DTIL - Enterprise Value
- business book valuation details:
Net Assets per Share Precision BioSciences|DTIL - Company Book Value|Market-to-Book Ratio precisionbiosciences.com|DTIL - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Precision BioSciences|DTIL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Precision BioSciences|DTIL - Company Aggregate Debts|Debts to Net Assets Precision BioSciences, Inc.|DTIL - Company Long-Term Debts|Short-Term Debt Precision BioSciences|Immediate Liquidity Ratio precisionbiosciences.com
- company profitability and valuation multiples indicators:
DTIL - Net Profit|Future Profit Precision BioSciences|DTIL - P/E Multiple|Projected Price to Earnings Ratio Precision BioSciences Inc.|DTIL - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Precision BioSciences, Inc.|DTIL - Operating profit EBITDA|Earnings per share for the last 12 months Precision BioSciences|DTIL - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months precisionbiosciences.com|DTIL - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Precision BioSciences
- sales and revenue data:
DTIL - Company Revenue|Company Projected Revenue Precision BioSciences|DTIL - P/S Multiple|Market Cap to Projected Revenue Precision BioSciences Inc.|DTIL - Sales Growth YoY (Last Twelve Months)
Summary company analytics:DTIL Precision BioSciences, Inc.
Signature product of Precision BioSciences

Value investors utilize this analysis to verify business recovery and avoid value traps. Precision BioSciences (DTIL) is developing the protected ARCUS platform, creating a technological barrier against competitors. The year-over-year sales growth percentage (over 4 quarters) measures rolling year revenue dynamics to identify trend reversals. The current value of 6359.10 reflects the operational efficiency of commercializing developments. Positive momentum here confirms the market demand for the proprietary nuclease.

Who Precision BioSciences competes with

Annual Revenue Growth (Last Twelve Months) Tempus AI, Inc (TEM)|QGEN: Revenue Growth YoY (Last 12 Months)|Ionis Pharmaceuticals (IONS) - Revenue Growth YoY (Last 12 Months)|Repligen (RGEN) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Avidity Biosciences, Inc.|Sales Growth YoY (Last Twelve Months) CRISPR Therapeutics|WGS - Revenue Growth Rate YoY (Last Twelve Months)|Sales Growth YoY (TTM) RARE|Revenue Change YoY (Last 12 Months) BEAM|Sales Growth YoY (TTM) SRPT (Sarepta Corp)|TWST - Revenue Growth YoY (Last 12 Months)|TXG: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Intellia Therapeutics|STOK: Sales Growth YoY (TTM)|BLFS - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) WVE|MAZE: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Sionna Corp (SION)|Annual Revenue Growth (Last Twelve Months) Prime Medicine Bio|Sales Growth YoY (TTM) TSHA (Taysha Gene Therapies Inc)|Sales Growth YoY (TTM) uniqure.com QURE|MeiraGTx Holdings - Sales Growth YoY (TTM)|RGNX - Sales Growth YoY (TTM)|SLDB (Solid Corp) - Revenue Growth YoY (Last 12 Months)|Revenue Growth Rate YoY (Last Twelve Months) Ocugen Corp OCGN|PACB (Pacific Biosciences) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BNTC|Sales Growth YoY (TTM) DSGN|Revenue Growth YoY (Last 12 Months) Rocket Pharma RCKT|Annual Revenue Growth (Last Twelve Months) FDMT|Sales Growth YoY (TTM) Lexeo Therapeutics LXEO|KRRO - Sales Growth YoY (Last Twelve Months)|EDIT (Editas Medicine, Inc.) - Sales Growth YoY (Last 12 Months)|SLN: Sales Growth YoY (TTM)|ProQR - Revenue Dynamics YoY (Last Twelve Months)|CDXS (Codexis) - Sales Growth YoY (TTM)|Sangamo (SGMO) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) NAUT|Revenue Growth YoY (Last 12 Months) Metagenomi, Inc. MGX|Sales Growth YoY (Last Twelve Months) Generation Bio Co. GBIO|BOLD: Sales Growth YoY (Last 12 Months)|XCUR: Revenue Growth YoY (Last 12 Months)|Imunon (IMNN) - Revenue Growth YoY (Last 12 Months)|PHIO (RXi Pharmaceuticals) - Revenue Growth YoY (Last 12 Months)|MBIO (Mustang Bio Inc) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) TransCode Therapeutics, Inc.|Sales Growth YoY (TTM) bionanogenomics.com|Sales Growth YoY (TTM) APDN|Sales Growth YoY (Last Twelve Months) BLUE (Bluebird Bio)|Sales Growth YoY (Last Twelve Months) ImmunoPrecise Antibodies Ltd. IPA|Revenue Dynamics YoY (Last Twelve Months) OMGA|singulargenomics.com - Sales Growth YoY (TTM)|Regulus Therapeutics Inc. - Revenue Change YoY (Last 12 Months)|SYRS: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TBIO|TCON (TRACON Pharmaceuticals) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) UBX (unitybiotechnology.com)